Abstract. We established a novel allergic dermatitis model in mouse ear lobes in which antigen-nonspecific inflammation was induced by painting 12-O-tetradecanoylphorbol 13-acetate (TPA) between sensitization and challenge with picryl chloride (PiCl). This model has an advantage for analyzing atopic dermatitis-like inflammation within a short period. Analysis of the time course changes in the PiCl-induced swelling showed that the allergic inflammation was shifted from a delayed-type response to a biphasic response consisting of a weak immediatephase response and a late-phase response by painting with TPA. The application of TPA increased the PiCl-induced infiltration of eosinophils and mast cells at the inflammatory site and shifted the cytokine milieu from Th1 to Th2. The expression of the Th2-inducing cytokine thymic stromal lymphopoietin (TSLP) mRNA was also increased by TPA. These findings suggested that the induction of antigen-nonspecific inflammation by TPA before the antigen challenge enhanced the Th2 response and modified the PiCl-induced delayed type-hypersensitivity. Using this model, we clarified that histamine plays significant roles in the early-phase swelling via H 1 receptors and the late-phase swelling via H 3 /H 4 receptors. Thus, we suggested the usefulness of the combined treatment with an H 1 antagonist and an H 4 antagonist for the suppression of atopic dermatitis.
Introduction
Atopic dermatitis is an allergic inflammatory disease characterized by intense pruritus, chronic eczematous plaques, and relapsing inflammation induced by repeated exposure to the antigen. In the inflamed skin, the infiltration of eosinophils, the number of mast cells, and Th2-type immune responses are generally increased (1, 2) . At present, there are several animal models of dermatitis with atopic dermatitis-like skin lesions. For example, repeated epicutaneous exposure to chemical compounds such as 2,4,6-trinitro-1-chlorobenzene (3 -5) and paraphenylenediamine (6) or dust mite allergen (7) resulted in chronic contact hypersensitivity. NC/ Nga mice have also been used as a model of atopic dermatitis (8 -10) . The contact hypersensitivity induced by contact-sensitizing chemicals such as picryl chloride (PiCl) involved Th1-dominant inflammation (3, 5) . However, repeated application leads to responses different from those induced by a single challenge. Repeated application of the antigen shifted the cytokine milieu from Th1 to Th2, resulting in increased infiltration of eosinophils and mast cells, and the induction of immediate-and latephase responses (3 -6) . Antigen-nonspecific inflammation, such as infection and scratching, worsens atopic dermatitis. Grabbe et al. (11) reported that antigennonspecific irritant applied with a small amount of the antigen enhanced the antigen-induced response. To clarify whether antigen-nonspecific inflammation induced before antigen challenge affects the antigeninduced immune response, we established a novel contact dermatitis model in mouse ear lobes in which antigen-nonspecific inflammation was induced by painting 12-O-tetradecanoylphorbol 13-acetate (TPA) between sensitization and challenge with PiCl (12) . Using this modified contact dermatitis model, we analyzed the shift to Th2-dominant inflammation and roles of thymic stromal lymphopoietin (TSLP) and histamine.
Establishment of a modified allergic dermatitis model in mouse ear lobes by application with TPA To induce blood eosinophila, cyclophosphamide was administered subcutaneously to male BALB/c mice (6 -8 weeks of age; Charles River Japan, Inc., Kanagawa) at a dose of 150 mg/kg as described by Satoh et al. (13) . Two days later, mice were sensitized with 50 μl of a 7% (w /v) PiCl (Nacalai Tesque, Inc., Kyoto) solution (3:1 in acetone : ethanol) or the vehicle by painting it on the right ear lobe (day 0). Thereafter, 20 μl of a 0.04 μg/μl TPA (Sigma-Aldrich, St. Louis, MO, USA) solution (3:1 in acetone : ethanol) was applied to the same site twice (days 5 and 10) to induce antigen-nonspecific inflammation. On day 12, mice were challenged with 20 μl of a 1% (w /v) PiCl solution or the vehicle by painting it on the right ear lobe (12) (Fig. 1) . Ear thickness was measured with a dial thickness gauge (Peacock; Ozaki MFG Co., Tokyo) at the indicated time. The ear lobe tissues were then obtained by using a punch (diameter 5.2 mm) and weighed. For the determination of the level of mRNA, the tissue samples were frozen in liquid nitrogen and stored at −80°C. The levels of mRNA for interferon (IFN)-γ, interleukin (IL)-4, TSLP, histidine decarboxylase (HDC), thymus and activation-regulated chemokine (TARC), and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) were determined by RT-PCR. For histological analysis, tissue specimens were immediately fixed in 10% neutral buffered formalin and embedded in paraffin. Sections, 4-μm thickness, were cut and stained with a Luxol-fast blue (EM Science, Cherry Hill, NJ, USA) solution for the detection of eosinophils or with a 0.05% (w /v) toluidine blue (EM Science) solution for the detection of mast cells. The numbers of eosinophils and mast cells were counted and expressed as the number of cells in the range of 0.25 mm (12) . The number of eosinophils in blood was determined by Giemsa staining.
We found that this model showed features similar to those observed in atopic dermatitis: crust formation, epidermal hyperplasia, and a vigorous infiltration of leukocytes including eosinophils (12) . Analysis of the time course changes in the PiCl-induced swelling showed that the allergic inflammation was shifted from a delayed-type response to a biphasic response consisting of a weak immediate-phase response and a late-phase response by painting with TPA (Fig. 2) . The number of mast cells in ear lobes was also increased by the treatment with TPA to about 1.8-fold. The challenge with PiCl on day 12 increased both the levels of mRNA for IFN-γ and IL-4 ( Fig. 3 , open columns). The application of TPA on days 5 and 10 decreased the level of IFN-γ mRNA, but increased that of IL-4 mRNA (Fig. 3 , hatched columns), indicating that the application of TPA induced a shift in the cytokine milieu from a Th1-to a Th2-type profile (12) . Thus, this model will be a suitable model for studying the mechanisms by which the antigennonspecific inflammation worsens allergic dermatitis. 
Putative involvement of TSLP
The precise mechanism for the change from Th1-dominant to Th2-dominant inflammation still remains to be clarified. TSLP has recently been reported to be implicated in the pathogenesis of atopic dermatitis. The main source of TSLP is epithelial cells including keratinocytes (14) . TSLP activates CD11c + dendritic cells and induces an expansion of the CD4 + T cell population (15) . Because skin-specific overexpression of TSLP (16) resulted in an atopic dermatitis-like phenotype, TSLP might be one of the inducers for the Th2-dominant immune response in atopic dermatitis. However, it has not been determined whether TSLP is expressed in the skin when the shift of cytokine milieu is induced in the contact dermatitis model. In our model, the application of TPA to the ear lobe of the PiClsensitized mice markedly increased the level of TSLP mRNA at 4 h (Fig. 4a) . The level was still significantly higher at 24 h (Fig. 4a) . TPA treatment without PiCl sensitization also increased the level of mRNA for TSLP at 4 h but not for other Th2 inducers TARC and IL-4 ( Fig. 4: b and c) . The level of mRNA for HDC at 4 h was also increased by TPA (Fig. 4: b and c) . Thus TPAinduced production of TSLP might be one of the probable mechanisms for the change in the immune balance to Th2-dominant. It is reported that TSLP has an activity to induce production of TARC, a chemokine for CD4
+ T cells (15) , in dendritic cells and IL-4, a Th2 cytokine, in CD4 + T cells (17) . However, 4 h after the TPA application, mRNA levels for TARC and IL-4 did not increase. Further study is necessary to clarify the involvement of TSLP in the enhancement of Th2 responses in this model.
Roles of histamine
Histamine, which is produced by HDC, plays significant roles in immediate-type allergic responses. Histamine also affects functions of immune and inflammatory cells. For example, histamine induces the production of TARC (18) and decreases the production of IL-12 in dendritic cells (19) , resulting in the induction of Th2-dominated responses. In addition, histamine has an activity to recruit mast cells and eosinophils via H 4 receptors, which are expressed on eosinophils (20) and mast cells (21) . In our model, the application of TPA significantly increased the number of mast cells (12) and the level of HDC mRNA (Fig. 4: b and c) , suggesting that histamine plays a more significant role compared with that in the delayed-type hypersensitivity model induced by PiCl alone. This was also supported by the finding that the challenge with PiCl on the TPA-treated ear lobe induced an increase in the thickness in the immediate-phase, which was suppressed by pyrilamine (Fig. 5a ). In contrast, the swelling 12 h after the PiCl challenge was more potently inhibited by thioperamide than by pyrilamine (Fig. 5b) . In our model, the treatment with cyclophosphamide and TPA increased the number of eosinophils in the inflamed tissue (12) , suggesting that a part of the late-phase response in this model might be elicited by eosinophils. We found that thioperamide inhibited the eosinophil infiltration consistent with the inhibition of the ear swelling in the late-phase (12) . The histamine-induced chemotaxis of eosinophils is inhibited by the specific H 4 antagonist JNJ7777120 (22) ; and in H 4 receptor-deficient mice, the infiltration of eosinophils in allergic airway inflammation is less extensive than that in wild-type mice (22) . We also found that the infiltration of eosinophils was less in HDC-deficient mice than that in wild-type mice, suggesting that histamine plays a role in the infiltration of eosinophils, probably through H 4 receptors, in allergic dermatitis in mice. In contrast, although histamine is reported to recruit mast cells via H 4 receptors (21), there was no statistically significant difference in the increase in the number of mast cells between our model and that in HDC-deficient mice. This finding suggested that histamine does not participate in mast cell infiltration.
Cyclosporin A and tacrolimus inhibit both immediateand delayed-type responses in mice (23) . These drugs inhibit the production of cytokines (24) and the antigeninduced degranulation of mast cells and basophils (25, 26) and thereby suppress allergic dermatitis (23, 27) . In our model, we confirmed that cyclosporin A inhibits the swelling of the ear lobe in both the immediate-phase and late-phase (Fig. 5 and Ref. 12) . Furthermore, we found that the combined treatment with pyrilamine and thioperamide inhibited the swelling of the ear lobe, being as strong as cyclosporin A (12) . These findings suggest that the combination of an H 1 antagonist with an H 4 antagonist might be a new strategy for the suppression of atopic dermatitis. 
Conclusion
We established a novel model for atopic dermatitis. In this model, we found that the induction of the antigennonspecific inflammation by TPA before the antigen challenge enhanced Th2 responses and modified the PiCl-induced delayed-type hypersensitivity (Figs. 2 and  3) . TPA increased the TSLP-mRNA level in the inflammatory site (Fig. 4) . In addition, our findings indicated that histamine is involved in the infiltration of eosinophils and ear swelling in the late-phase via the H4 receptor as well as the swelling in the immediate-phase via the H 1 receptor (Fig. 5) . Thus, TSLP and histamine might be involved in the TPA-induced changes of contact dermatitis. Finally, we suggested the usefulness of the combined treatment with an H 1 antagonist and an H 4 antagonist for the suppression of atopic dermatitis. Pharmacological features of this TPA-modified allergic dermatitis model are summarized in Table 1 . Proposed mechanisms for how histamine and TSLP are involved in the induction of the TPA-modified atopic dermatitis model are summarized in Fig. 6 . 
